TORONTO, June 30 /CNW/ - MDS Inc. (TSX: MDS, NYSE: MDZ), a leading
provider of enabling products and services to the global life sciences
markets, announced today that the Toronto Stock Exchange (TSX) accepted the
Company's Notice of Intention to make a normal course issuer bid for a
one-year period.
